Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Adverse drug events

Association between SSRI use and violent crime could be explained by poor adherence

Younger sample group showed greater propensity to violence while using SSRI antidepressants.

An association between the use of a class of antidepressant known as selective serotonin reuptake inhibitors (SSRIs) and violent crime in patients aged 15-24 years has been found by researchers in Sweden and the UK. In the image, a police van

Source: Kevin Smith / Alamy Stock Photo

Researchers identified a link between SSRI antidepressant use and convictions for violent crimes in people aged 15–24 years but not for older individuals

An association between the use of a class of antidepressant known as selective serotonin reuptake inhibitors (SSRIs) and violent crime in patients aged 15–24 years has been found by researchers in Sweden and the UK. The same association was not seen in patients aged 25 years and over, and no causal link has been made. 

The research team, led by Seena Fazel, professor of forensic psychiatry at the University of Oxford, compared data from 856,493 people who had been prescribed SSRIs between 2006 and 2009. They looked at the rate of violent crime while the subjects were prescribed SSRIs, and compared it with the rate of violent crime in the same individuals while they were not taking SSRIs. Matched data were taken from the Swedish Prescribed Drug Register and the Swedish national crime register. 

There was a significant association between SSRI use and convictions for violent crimes in people aged 15–24 years but not for older individuals. Increased risks were also found in the younger group for violent arrests, non-violent convictions and arrests, non-fatal accidental injuries and emergency contacts for alcohol problems. 

There are too many confounding factors at play in a study of this scale to make any causal link, but the findings mark an important step forward, says Fazel, whose Wellcome Trust-funded study was published in the open access journal PLoS Medicine[1] on 15 September 2015. “There’s a signal here, but there isn’t an interpretation.” 

In some cases, he points out, a lower dose of the drug was associated with a higher risk of violent behaviour. It is possible, suggests Fazel, that a failure to adhere to the recommended prescription might lead to periods of withdrawal and subsequent extremes in behaviour. An individual “might take a few tablets, feel a bit better and then binge drink”, he says. 

The message, adds Fazel, is: “Take the prescribed course according to recommendations from your doctor.” Far from suggesting that patients should stop taking SSRIs, Fazel compares these drugs to antibiotics: “It’s important to take the agreed prescription.” 

Whether young adults are not so good at adhering to their prescriptions is difficult to determine. Although that is a possibility, the age range also covers the period during which, in previous studies, suicidal thoughts have been associated with SSRI use. “There might be something about younger people and how they respond to SSRIs,” he says. 

“If patients are getting side effects; [the drug] is making patients more hostile, they should go back to their doctors,” says Fazel. He suggests that information relating to these associations could be added to the drug labelling, so the patient or carer knows what to be aware of. “Having a fuller disclosure of the possible risks is important,” he adds. 

Ian Maidment, senior lecturer in clinical pharmacy at Aston University, says: “The risks identified by the study need to be validated through replication. At this stage, it can only be seen as a preliminary signal that SSRI antidepressants are associated with violent crime in certain populations.”

As with all cohort studies, there is the possibility that unknown confounders may not have been identified, he added. “But this study adds to the evidence that young people react differently to SSRIs compared with other age groups.” 

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20069368

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Clinical Pharmacokinetics

    Clinical Pharmacokinetics

    A practical guide to the use of pharmacokinetic principles in clinical practice. Includes case studies with questions and answers.

    £33.00Buy now
  • Strategic Medicines Management

    Strategic Medicines Management

    A practical guide to influencing the availability of medicines, and policies of their use. Focuses on the strategic elements of medicines management.

    £33.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • An association between the use of a class of antidepressant known as selective serotonin reuptake inhibitors (SSRIs) and violent crime in patients aged 15-24 years has been found by researchers in Sweden and the UK. In the image, a police van

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.